Case Control Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Feb 21, 2015; 21(7): 2073-2079
Published online Feb 21, 2015. doi: 10.3748/wjg.v21.i7.2073
Table 4 Evaluation of hepatitis B e antigen/anti- hepatitis B e seroconversion with Kaplan-Meier analysis n (%)
nHBeAg(-)antiHBe(+)HBeAg(+)/anti-HBe(-)Seroconversion annual Rate
Group 1243 (12.5)21 (87.5)1.61%
Group 22515 (60.0)10 (40.0)16.66%
Total4918 (36.7)31 (63.3)8.33%